Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Anthony BuissonMélanie SerreroLaurie OrsatStéphane NanceyPauline RivièreRomain AltweggLaurent Peyrin-BirouletMaria NachuryXavier HébuterneCyrielle GillettaMathurin FlamantStéphanie ViennotGuillaume BouguenAurélien AmiotStéphane MathieuLucine VuittonLaurianne PlastarasArnaud BourreilleLudovic CailloFélix GoutorbeGuillaume Pineton De ChambrunAlain AttarXavier RoblinBruno PereiraMathurin FumeryPublished in: Inflammatory bowel diseases (2022)
Although oral intake is overall preferred, acceptability is highly impacted by the rhythm of administration and prior medication exposures. However, SC treatment with long intervals between 2 injections (≥8 weeks) and oral intake once daily seems to be the most accepted modalities.